Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Anthony Montag
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
Available to PurchaseMarion Zillhardt, Sun-Mi Park, Iris L. Romero, Kenjiro Sawada, Anthony Montag, Thomas Krausz, S. Diane Yamada, Marcus E. Peter, Ernst Lengyel
Journal:
Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4042–4051.
Published: 15 June 2011
Includes: Supplementary data
Journal Articles
Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis
Available to PurchaseHilary A. Kenny, Payton Leonhardt, Andras Ladanyi, S. Diane Yamada, Anthony Montag, Hae Kyung Im, Sujatha Jagadeeswaran, David E. Shaw, Andrew P. Mazar, Ernst Lengyel
Journal:
Clinical Cancer Research
Clin Cancer Res (2011) 17 (3): 459–471.
Published: 01 February 2011
Includes: Supplementary data
Journal Articles
Nuclear Receptor Agonists As Potential Differentiation Therapy Agents for Human Osteosarcoma
Available to PurchaseRex C. Haydon, Lan Zhou, Tao Feng, Benjamin Breyer, Hongwei Cheng, Wei Jiang, Akira Ishikawa, Terrance Peabody, Anthony Montag, Michael A. Simon, Tong-Chuan He
Journal:
Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1288–1294.
Published: 01 May 2002